Lind van Wijngaarden, R.F.A. de

children gh treatment prader-willi syndrome treatment level syndrome study scoliosi growth prader-willi patient effect hormone group body composition igf-i metyrapone test height metyrapone prepubertal children month growth hormone treatment prepubertal control endocrinol result composition infant cortisol apnea table apnea index randomized baseline metab asp levels 24 months blood gh-treated body mass glucose serum prevalence control group pws patients increase change pressure index igf-i sds randomized controls chapter growth hormone value gh-treated children 2 years center sleep-related breathing pediatr pws children insulin breathing cortisol levels response bone mineral density insufficiency dutch death igf-i levels model figure difference reference sleep-related onset lind van wijngaarden mineral body mass index 1.1 j med genet